Ubiquitin Conjugating enzyme E2C
Ubiquitin Conjugating enzyme E2C (EC 2.3.2.24) is a member of the E2 ubiquitin-conjugating enzyme family, and it is the principal regulator of pathways for protein degradation in eukaryotes. Ubiquitin Conjugating enzyme E2C is involved in the tumorigenesis of various malignancies. Ubiquitin Conjugating enzyme E2C is also involved in mitotic cyclin disruption, affecting cell cycle progression. Ubiquitin Conjugating enzyme E2C is a prognostic indicator for cholangiocarcinoma[1].
Product Specifications
UNSPSC
12352211
Target
E1/E2/E3 Enzyme
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[UbiquitinConjugatingenzymeE2C]
References & Citations
[1]Khaa Hoo Ong, et al. Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma. Eur J Med Res. 2023 Dec 15;28 (1) :593.
Shipping Conditions
Room temperature
Scientific Category
Enzyme
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6373311-01 0.1 mL
CD86 (T-lymphocyte Activation Antigen CD86, Activation B7-2 Antigen, B70, BU63, CTLA-4 Counter-receptor B7.2, FUN-1, CD28LG2) (PE)
Sign In for Pricing
View Details MBS6373311-02 5x 0.1 mL
CD86 (T-lymphocyte Activation Antigen CD86, Activation B7-2 Antigen, B70, BU63, CTLA-4 Counter-receptor B7.2, FUN-1, CD28LG2) (PE)
Sign In for Pricing
View Details GTR15388814 1 Vial
Lentiviral human TOM1 sgRNA gene knockout kit - Lentiviral human TOM1 sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details